{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:25Z","timestamp":1788303985106,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.braindev.2023.02.003","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:57:43Z","timestamp":1677488263000},"page":"348-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure"],"prefix":"10.1016","volume":"45","author":[{"given":"Seoyun","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hee","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Chan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2023.02.003_b0005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2013pathogenesis, associated disorders, and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.braindev.2023.02.003_b0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"issue":"14","key":"10.1016\/j.braindev.2023.02.003_b0015","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.braindev.2023.02.003_b0020","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.braindev.2023.02.003_b0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2023.02.003_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577008","article-title":"LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome","volume":"335","author":"Nosadini","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.braindev.2023.02.003_b0035","doi-asserted-by":"crossref","unstructured":"Alotaibi W, Bashir S, Mir A. Faciobrachial Dystonic Seizures as a Sign of Relapse in a Child with LGI-1 Encephalitis. Child Neurol Open. 2022;9:2329048X221105960.","DOI":"10.1177\/2329048X221105960"},{"issue":"3","key":"10.1016\/j.braindev.2023.02.003_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11910-015-0529-1","article-title":"Autoimmune encephalitis and its relation to infection","volume":"15","author":"Venkatesan","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"46","key":"10.1016\/j.braindev.2023.02.003_b0045","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.braindev.2023.02.003_b0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.braindev.2023.02.003_b0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.braindev.2023.02.003_b0060","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.braindev.2023.02.003_b0065","article-title":"Super refractory status epilepticus secondary to anti-GAD antibody encephalitis successfully treated with aggressive immunotherapy","volume":"14","author":"Jaafar","year":"2020","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.braindev.2023.02.003_b0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2018.07.016","article-title":"Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases","volume":"86","author":"Randell","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2023.02.003_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.braindev.2023.02.003_b0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/RLU.0000000000000546","article-title":"18F-FDG PET\/CT in anti-LGI1 encephalitis: initial and follow-up findings","volume":"40","author":"Park","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.braindev.2023.02.003_b0085","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fneur.2020.00418","article-title":"The Clinical Value of (18) F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:51:37Z","timestamp":1759953097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760423000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0387760423000268"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2023.02.003","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2023.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of The Japanese Society of Child Neurology. All rights reserved.","name":"copyright","label":"Copyright"}]}}